Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid.
暂无分享,去创建一个
[1] E. Worcester,et al. Osteopontin Inhibits Nucleation of Calcium Oxalate Crystals a , 1995, Annals of the New York Academy of Sciences.
[2] N. Mandel,et al. Crystal-membrane interaction in kidney stone disease. , 1994, Journal of the American Society of Nephrology : JASN.
[3] N. Garti,et al. The Influence of Surfactants on the Crystallization of Calcium Oxalate Hydrates , 1994 .
[4] P. C. Rieke,et al. Ceramic Thin-Film Formation on Functionalized Interfaces Through Biomimetic Processing , 1994, Science.
[5] W. Grzeszczak,et al. [Pathogenesis and treatment of kidney stones]. , 1994, Wiadomosci lekarskie.
[6] M. Jewett,et al. Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. , 1994, The Journal of urology.
[7] D. Denhardt,et al. Osteopontin: a protein with diverse functions , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] E. Worcester,et al. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] E. Neilson,et al. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] N. Mandel,et al. Crystal-cell interactions: crystal binding to rat renal papillary tip collecting duct cells in culture. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[11] R. Ryall,et al. Does Tamm-Horsfall mucoprotein inhibit or promote calcium oxalate crystallization in human urine? , 1990, Clinica chimica acta; international journal of clinical chemistry.
[12] G. Mandel,et al. Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. , 1989, The Journal of urology.
[13] G. Mandel,et al. Urinary tract stone disease in the United States veteran population. I. Geographical frequency of occurrence. , 1989, The Journal of urology.
[14] W. Butler,et al. The nature and significance of osteopontin. , 1989, Connective tissue research.
[15] J. Garancis,et al. Calcium oxalate crystal interaction with rat renal inner papillary collecting tubule cells. , 1987, The Journal of urology.
[16] S. Ljunghall,et al. Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth. , 1986, Clinica chimica acta; international journal of clinical chemistry.
[17] G. Mandel,et al. Membrane interactions with calcium oxalate crystals: variation in hemolytic potentials with crystal morphology. , 1986, The Journal of urology.
[18] L. Smith,et al. EQUIL2: a BASIC computer program for the calculation of urinary saturation. , 1985, The Journal of urology.
[19] S. Weiner,et al. Interactions between acidic proteins and crystals: stereochemical requirements in biomineralization. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[20] L. Smith,et al. Calcium oxalate dihydrate formation in urine. , 1984, Kidney international.
[21] J. S. Elliot,et al. Calcium oxalate crystalluria: crystal size in urine. , 1980, The Journal of urology.
[22] H. Fleisch. Inhibitors and promoters of stone formation. , 1978, Kidney international.
[23] H. Ito,et al. Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine. , 1977, The American journal of physiology.